Neurology Minute

Dr. Andrew J. Solomon discusses the diagnosis of multiple sclerosis in the second of a three-part series. To learn more, read the article "Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis" by Dr. Solomon in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. This article is open to all at continpub.com/DiagnosisMS.

Dr. Andrew J. Solomon discusses the diagnosis of multiple sclerosis in the first of a three-part series. To learn more, read the article "Diagnosis, Differential Diagnosis, and Misdiagnosis of Multiple Sclerosis" by Dr. Solomon in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum. This article is open to all at continpub.com/DiagnosisMS.

Dr. Gross discusses a challenging experience from his time as Editor-in-Chief of Neurology, from the longer second part of the interview available through the Neurology Podcast.

Dr. Eoin Flanagan discusses NMOSD in the third of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.

Dr. Jason Crowell discusses Richard Robinson's article on an antisense oligonucleotide therapy for a rare variant of Batten Disease. To learn more, read the article "An Antisense Oligonucleotide Therapy Looks Promising for a Rare Form of Batten Disease" by Robinson in the June 20, 2019, issue of Neurology Today—available online at http://bit.ly/NT-Batten.

Dr. Eoin Flanagan discusses NMOSD in the second of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.

Dr. Eoin Flanagan discusses NMOSD in the first of a three-part series. To learn more, read the article "Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases" by Dr. Flanagan in the June 2019 Multiple Sclerosis and Other CNS Inflammatory Diseases issue of Continuum.

Dr. Bob Gross, Editor-in-Chief of the Neurology family of journals, discusses changes in publishing and media as well as how the journal will differentiate itself from non-peer reviewed sources of digital media in the future.

Dr. Joseph Kass discusses driving and epilepsy in the second of a three-part series. To learn more, read the article "Driving and Epilepsy: Ethical, Legal, and Health Care Policy Challenges" by Dr. Kass in the April 2019 Epilepsy issue of Continuum.

Dr. Joseph Kass discusses driving and epilepsy in the first of a three-part series. To learn more, read the article "Driving and Epilepsy: Ethical, Legal, and Health Care Policy Challenges" by Dr. Kass in the April 2019 Epilepsy issue of Continuum.

Dr. Jennifer Hopp discusses treating patients with nonepileptic episodic events in the third of a three-part series. To learn more, read the article "Nonepileptic Episodic Events" by Dr. Hopp in the April 2019 Epilepsy issue of Continuum.

Dr. P. James B. Dyck discusses takeaways about his paper, from the March 12th issue, on the incidence of lumbrosacral radiculoplexus neuropathy and association with diabetes mellitus.

Dr. Jennifer Hopp discusses nonepileptic episodic events in the second of a three-part series. To learn more, read the article "Nonepileptic Episodic Events" by Dr. Hopp in the April 2019 Epilepsy issue of Continuum.

Dr. Jennifer Hopp discusses differentiating epileptic versus nonepileptic events in the first of a three-part series. To learn more, read the article "Nonepileptic Episodic Events" by Dr. Hopp in the April 2019 Epilepsy issue of Continuum.

Dr. Mona Sazgar discusses tips for treating menopausal women with epilepsy in the third of a three-part series. To learn more, read the article "Treatment of Women with Epilepsy" by Dr. Sazgar in the April 2019 Epilepsy issue of Continuum.

Dr. Deborah Dowell discusses takeaways on her article on opioid prescribing and safe treatment.

Dr. Mona Sazgar discusses tips for treating women with catamenial epilepsy in the second of a three-part series. To learn more, read the article "Treatment of Women with Epilepsy" by Dr. Sazgar in the April 2019 Epilepsy issue of Continuum.

Dr. Mona Sazgar discusses tips for treating women with epilepsy in the first of a three-part series. To learn more, read the article "Treatment of Women with Epilepsy" by Dr. Sazgar in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan Pulst discusses approaches to diagnosing genetic ataxias.

Dr. Brian Callaghan talks about the rise in out-of-pocket costs for commonly prescribed neurologic medications.

Dr. Derek Bauer discusses how to optimize epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Derek Bauer offers tips for epilepsy neurologists with more experience in optimizing epilepsy management. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Derek Bauer discusses optimizing management of medically responsive epilepsy. To learn more, read the article "Optimizing Management of Medically Responsive Epilepsy" by Dr. Bauer in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan U. Schuele offers important takeaways in evaluating seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Stacey Clardy discusses discusses takeaways from Dr. Annie Lannuzel's paper on the long-term outcomes of NeuroZika.

Dr. Stuart Connolly discusses the main takeaways from his NEJM paper on andexanet alfa for Bleeding Associated with Factor Xa Inhibitors. Read the paper in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMoa1814051.

Dr. Jason Crowell discusses the importance of talking to legislators about PCORI. Share your story on the AAN Advocacy Action Center at https://www.aan.com/policy-and-guidelines/advocacy/aan-advocacy-action-center/.

Dr. Stephan U. Schuele discusses the evaluation of seizure etiology for neurologists with more experience. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Stephan U. Schuele discusses the evaluation of seizure etiology. To learn more, read the article "Evaluation of Seizure Etiology from Routine Testing to Genetic Evaluation" by Dr. Schuele in the April 2019 Epilepsy issue of Continuum.

Dr. Ivan Sanchez Fernandez discusses the main points from his paper on meta-analysis and cost-effectiveness of second-line antiepileptic drugs for status epilepticus.

Dr. Anthony Fauci discusses the main points on his paper on measles in 2019. "Measles in 2019--Going Backward" can be found in the New England Journal of Medicine here: https://www.nejm.org/doi/full/10.1056/NEJMp1905099.

Dr. Jason Crowell discusses STEP therapy and recent advocacy efforts by the AAN at Neurology on the Hill. Read the AAN Capitol Hill Report from April 22nd for more: https://www.aan.com/policy-and-guidelines/advocacy/capitol-hill-report/.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses posterior cortical atrophy. To learn more, read the article "Posterior Cortical Atrophy" by Dr. Jonathan M. Schott and Dr. Sebastian J. Crutch in that issue.

Dr. Tamara Pringsheim discusses guideline recommendations on assessment and management of tics in people with Tourette's Syndrome and chronic tic disorders.

New York Times staff writer Pam Belluck discusses the WHO and regulation on human gene editing. Read her March 19, 2019, article here: https://www.nytimes.com/2019/03/19/health/who-panel-demands-a-registry-for-human-gene-editing.html.

Dr. Jason Crowell discusses skyrocketing costs of a drug used for treatment with Lambert-Eaton myasthenic syndrome.

Dr. Rae Bacharach discusses trends in medical clerkships in neurology.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Continuum Dementia issue, discusses early-onset Alzheimer Disease. To learn more, read the article "Early-onset Alzheimer Disease and Its Variants" by Dr. Mario F. Mendez in that issue.

Dr. Jenny Linnoila discusses the main takeaways from her podcast interview and paper on a mouse model of anti-NMDA receptor post-herpes simplex encephalitis.

Pam Belluck of the New York Times discusses He Jiankui, gene editing and CRISPR. Read one of the articles on the issue here: https://www.nytimes.com/2019/04/14/health/gene-editing-babies.html

Dr. Rae Bacharach discusses two new, disease-modifying therapies for use in multiple sclerosis.

Dr. Gregory Day discusses the recognition of transient epileptic amnesia. To learn more, read Dr. Day's article, "Reversible Dementias," in the February 2019 Dementia issue of Continuum.

Dr. Brigid Waldron-Perrine talks about the Montreal Cognitive Assessment as a screening tool.

Dr. Mathias Jucker discusses the use of neurofilament light as a potential biomarker for Alzheimer's Disease.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses behavioral-variant frontotemporal dementia. To learn more, read the article "Behavioral Variant Frontotemporal Dementia" by Dr. William W. Seeley in that issue.

Dr. Mathias Buron discusses the takeaways from his paper the comparative effectiveness of teriflunomide and dimethyl fumarate.

Dr. Joanna Hellmuth discusses the findings of her paper on the rise of pseudomedicine for dementia and brain health.

Dr. Roy Strowd discusses a recent Clinical Reasoning case about a 65-year-old female with subacute hemiballism.

Dr. Jonathan Graff-Radford, guest editor of the February 2019 Dementia issue of Continuum, discusses hippocampal sclerosis of aging. To learn more, read the article "Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-related Tauopathy" by Drs. Gregory A. Jicha and Peter T. Nelson in that issue.

Dr. Caterina Lapucci talks about her paper addressing how much periventricular lesions assist in distinguishing migraine with aura from CIS.